TITLE

Cetuximab labeling revised for KRAS mutations

PUB. DATE
August 2009
SOURCE
Hem/Onc Today;8/10/2009, Vol. 10 Issue 15, p1
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on the approval by the U.S. Food and Drug Administration (FDA) on revisions to the drug labeling of cetuximab used for treating patients with epidermal growth factor receptor.
ACCESSION #
43476034

 

Related Articles

  • FDA proposes new drug guides for consumers.  // HealthFacts;Oct95, Vol. 20 Issue 197, p2 

    Reports that the Food and Drug Administration (FDA) is proposing a new standard for drug guides for consumers. Flaws of the plan as including inability of the FDA to meet their own standards; Medication guide for the antibiotic Ceclor as FDA's prototype.

  • Recent changes to FDA-approved labeling.  // American Journal of Health-System Pharmacy;3/15/2003, Vol. 60 Issue 6, p544 

    Focuses on the changes made in the labeling approved by the U.S. Food & Drug Administration. Changes made in the brand of Estradiol; Benefits of Paroxetine hydrochloride; Warning added to the Sirolimus oral solution and tablets.

  • Standardized over-the-counter labels are not all-over-the-map. Greenberg, Eric F. // Packaging Digest;Jun2002, Vol. 39 Issue 6, p30 

    Focuses on the standardization for the labels of over-the-counter (OTC) drugs in the U.S. Features of an OTC label described by the U.S. Food and Drugs Administration (FDA); Graphics and formatting specifications to be used for the drug label; Changes in the product packages to meet the design...

  • Labeling changed on Prezista.  // AIDS Alert;Mar2010, Vol. 25 Issue 3, p34 

    The article informs that the Food and Drug Administration (FDA) in the U.S. has approved revisions to the drug darunavir product labeling to include the 96 week data from two clinical trials.

  • Updated Atripla label approved.  // AIDS Alert;Mar2010, Vol. 25 Issue 3, p36 

    The article informs that the Food and Drug Administration (FDA) in the U.S. has approved an updated label for the drug atripla.

  • Etravirine label updated by FDA.  // AIDS Alert;May2010, Vol. 25 Issue 5, p59 

    The article reports on the update of the label for the drug, Etravirine, by the U.S. Food and Drug Administration (FDA).

  • Recent changes to FDA-approved labeling.  // American Journal of Health-System Pharmacy;1/1/2003, Vol. 60 Issue 1, p26 

    Provides information on the labeling of pharmaceuticals approved by the U.S. Federal Drug Administration. Description of pharmaceuticals; Usage of pharmaceuticals.

  • FDA to hold public meeting on drug labeling.  // Primary Care Weekly;10/16/95, Vol. 1 Issue 26, p5 

    Reports that the US Food and Drug Administration (FDA) will hold a public meeting on October 30, 1995 to present research on how approved prescription-drug product labeling may be adapted to communicate more effectively to health care providers. Schedule of the meeting; Contact information.

  • FDA defends control. Dickinson, James G. // Medical Marketing & Media;May2003, Vol. 38 Issue 5, p20 

    Reports that the U.S. Food and Drug Administration (FDA) will defend its drug labeling policy in court cases. Proliferation of state law actions; Risk management responsibility of FDA; Prescription drug advertising.

  • Recent changes to FDA-approved labeling.  // American Journal of Health-System Pharmacy;2/1/2003, Vol. 60 Issue 3, p219 

    Provides information on changes to medication labeling recently approved by the U.S. Food and Drug Administration as of February 1, 2003. Caspofungin acetate injection; Dalterpain sodium injection; Fluticason dipropionate inhalation powder.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics